吸入式一酸化窒素の世界市場規模調査：用途別、地域別予測：2022～2032年

世界の吸入式一酸化窒素市場は、2023年に約11億2,000万米ドルとなり、予測期間の2024年から2032年にかけて7.70％以上の健全な成長率で成長すると予測されています。

吸入式一酸化窒素（iNO）は、特定の呼吸困難に直面している人の酸素供給を改善する治療薬として使用される医療用ガスです。一酸化窒素は肺の血管を拡張し、効果的な酸素交換に不可欠な部位への血流を促進することで機能します。一酸化窒素は体内で自然に生成される分子で、血管拡張と血圧調節に関与しています。iNOは、肺の酸素が豊富な部位を取り囲む血管をターゲットとし、弛緩と血流の亢進を促し、赤血球による最適な酸素取り込みを促進します。この標的作用は、新生児呼吸器治療、慢性閉塞性肺疾患、急性呼吸窮迫症候群などの治療に不可欠です。従って、iNOは、特に新生児や重症患者における血管と酸素化の問題を管理する上で重要な役割を果たします。成人におけるiNO療法の有効性と安全性を裏付ける確固たる臨床エビデンスは、世界の吸入式一酸化窒素市場の成長を支える重要な動向です。

吸入式一酸化窒素市場の成長は、呼吸器疾患の有病率の上昇やヘルスケアインフラの進歩と相まって、乳幼児や新生児の肺疾患を管理するための採用が増加しているため、大幅に急増すると予想されます。また、特に新生児の様々な肺疾患の治療における吸入式一酸化窒素の有効性に関する認識が高まっており、これが2024年から2032年の推定期間中の市場拡大を支えています。例えば、国立心肺血液研究所の2022年の論文では、一過性頻呼吸、新生児呼吸窮迫症候群（RDS）、新生児遷延性肺高血圧症（PPHN）、メコニウム誤嚥症候群、気管支肺異形成（BPD）など、新生児に影響を及ぼす呼吸問題の範囲が強調されています。PPHNは肺血管抵抗の亢進を特徴とする重篤な病態であり、一酸化窒素吸入療法の主要な適応です。そのメカニズムには、肺血管の選択的拡張、酸素化の促進、侵襲的換気法への依存の軽減が含まれます。さらに、米国食品医薬品局が低酸素性呼吸不全の治療に吸入式一酸化窒素を承認したことが、その採用をさらに後押ししています。その結果、新生児の呼吸器合併症を管理するために吸入式一酸化窒素の採用が急増し、吸入式一酸化窒素市場の予測成長率を押し上げることになります。さらに、吸入式一酸化窒素に焦点を当てた集中的な研究開発活動は、この治療用ガス市場に大きな成長機会をもたらすと予測されています。吸入式一酸化窒素は、肺や心血管系のさまざまな症状に対する有望な治療薬として大きな関心を集めています。現在進行中の医学と技術の進歩は、吸入式一酸化窒素の革新的な応用と製剤の調査に拍車をかけ、製薬会社や研究機関による研究開発への投資の高まりを促しています。これらのイニシアチブは、送達メカニズムや投与プロトコルを改良し、吸入式一酸化窒素療法の適応範囲を広げることを目的としています。しかし、様々な地域で厳しい適用基準があり、処置にかかるコストが高いため、2022年から2032年にかけての市場成長の妨げになると予想されます。

世界の吸入式一酸化窒素市場の調査で考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、世界のその他の地域が含まれます。2023年、北米は吸入式一酸化窒素市場において支配的な地域であり、予測期間を通じて最も高い市場シェア数で主導的地位を維持すると予測されます。高度なヘルスケア施設の存在や、吸入式一酸化窒素のような革新的な治療法の採用を促進する実質的な医療費水準といった主な要因が、主にこの地域の市場成長を後押ししています。さらに、北米は広範な研究開発イニシアチブの恩恵を受けており、有利な規制状況と相まって、同地域における吸入式一酸化窒素製品の進歩と商業的利用可能性を促進しています。一方、アジア太平洋の市場は、慢性閉塞性肺疾患（COPD）、肺高血圧症、新生児低酸素性呼吸不全などの呼吸器疾患の有病率の上昇により、予測期間中に最も速い速度で成長すると予測されています。

本レポートに含まれる主な市場プレイヤーは以下の通りです：

• Air Liquide Healthcare (France)
• SOL Group (Italy)
• Matheson Tri-Gas Inc. (United States)
• Merck KGaA (Germany)
• Mallinckrodt Pharmaceuticals (United Kingdom)
• Nu-Med Plus Inc. (United States)
• Perma Pure LLC (United States)
• Praxair Distribution Inc. (United States)
• HALMA PLC (United Kingdom)
• LINDE PLC (Germany)

目次

第1章 世界の吸入式一酸化窒素市場の定義と調査の前提条件

• 調査目的
• 市場の定義
• 調査の前提条件
  • 包含事項・除外事項
  • 制限事項
  • 供給サイド分析
    • 入手可能性
    • インフラ
    • 規制環境
    • 市場競争
    • 経済性（消費者の視点）
  • 需要サイド分析
    • 規制の枠組み
    • 技術の進歩
    • 環境への配慮
    • 消費者の意識と受容
• 調査手法
• 調査対象年
• 通貨換算レート

第2章 エグゼクティブサマリー

• 吸入式一酸化窒素の世界市場規模・予測（2022～2032年）
• 地域別概要
• セグメント別概要
  • 用途別
• 主要動向
• 不況の影響
• アナリストの結論・提言

第3章 吸入式一酸化窒素の世界市場力学

• 市場促進要因
• 市場の課題
• 市場機会

第4章 吸入式一酸化窒素の世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • ポーターのファイブフォースモデルへの未来的アプローチ
  • ポーターのファイブフォースの影響分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主要な投資機会
• 主要な成功戦略
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 吸入式一酸化窒素の世界市場規模・予測：用途別、2022～2032年

• 新生児呼吸器治療
• 慢性閉塞性肺疾患
• 急性呼吸窮迫症候群
• その他

第6章 吸入式一酸化窒素の世界市場規模・予測：地域別、2022～2032年

• 北米の吸入式一酸化窒素市場
  • 米国
    • 用途の内訳規模・予測、2022～2032年
  • カナダの吸入式一酸化窒素市場
• 欧州の吸入式一酸化窒素市場
  • 英国の吸入式一酸化窒素市場
  • ドイツの吸入式一酸化窒素市場
  • フランスの吸入式一酸化窒素市場
  • スペインの吸入式一酸化窒素市場
  • イタリアの吸入式一酸化窒素市場
  • その他欧州の吸入式一酸化窒素市場
• アジア太平洋の吸入式一酸化窒素市場
  • 中国の吸入式一酸化窒素市場
  • インドの吸入式一酸化窒素市場
  • 日本の吸入式一酸化窒素市場
  • オーストラリア吸入式一酸化窒素市場
  • 韓国の吸入式一酸化窒素市場
  • その他アジア太平洋の吸入式一酸化窒素市場
• ラテンアメリカの吸入式一酸化窒素市場
  • ブラジルの吸入式一酸化窒素市場
  • メキシコの吸入式一酸化窒素市場
  • その他ラテンアメリカの吸入式一酸化窒素市場
• 中東・アフリカの吸入式一酸化窒素市場
  • サウジアラビアの吸入式一酸化窒素市場
  • 南アフリカの吸入式一酸化窒素市場
  • その他中東・アフリカの吸入式一酸化窒素市場

第7章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Air Liquide Healthcare（France）
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 市場戦略
  • SOL Group（Italy）
  • Matheson Tri-Gas Inc.（United States）
  • Merck KGaA（Germany）
  • Mallinckrodt Pharmaceuticals（United Kingdom）
  • Nu-Med Plus Inc.（United States）
  • Perma Pure LLC（United States）
  • Praxair Distribution Inc.（United States）
  • HALMA PLC（United Kingdom）
  • LINDE PLC（Germany）

第8章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性

LIST OF TABLES

• TABLE 1.Global Inhaled Nitric Oxide Market, report scope
• TABLE 2.Global Inhaled Nitric Oxide Market estimates & forecasts by Region 2022-2032 (USD Billion)
• TABLE 3.Global Inhaled Nitric Oxide Market estimates & forecasts by Application 2022-2032 (USD Billion)
• TABLE 4.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 5.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 6.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 7.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 8.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 9.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 10.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 11.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 12.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 13.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 14.U.S. Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 15.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 16.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 17.Canada Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 18.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 19.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 20.UK Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 21.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 22.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 23.Germany Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 24.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 25.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 26.France Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 27.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 28.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 29.Italy Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 30.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 31.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 32.Spain Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 33.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 34.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 35.RoE Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 36.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 37.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 38.China Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 39.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 40.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 41.India Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 42.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 43.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 44.Japan Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 45.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 46.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 47.Australia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 48.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 49.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 50.South Korea Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 51.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 52.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 53.
• TABLE 54.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 55.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 56.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 57.Brazil Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 58.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 59.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 60.Mexico Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 61.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 62.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 63.RoLA Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 64.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 65.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 66.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 67.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 68.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 69.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 70.
• TABLE 71.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 72.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 73.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 74.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 75.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 76.List of secondary sources, used in the study of Global Inhaled Nitric Oxide Market.
• TABLE 77.List of primary sources, used in the study of Global Inhaled Nitric Oxide Market.
• TABLE 78.Years considered for the study.
• TABLE 79.Exchange rates considered.

LIST OF FIGURES

• FIG 1.Global Inhaled Nitric Oxide Market, research methodology
• FIG 2.Global Inhaled Nitric Oxide Market, market estimation techniques
• FIG 3.Global market size estimates & forecast methods.
• FIG 4.Global Inhaled Nitric Oxide Market, key trends 2023
• FIG 5.Global Inhaled Nitric Oxide Market, growth prospects 2022-2032
• FIG 6.Global Inhaled Nitric Oxide Market, porters 5 force model
• FIG 7.Global Inhaled Nitric Oxide Market, pestel analysis
• FIG 8.Global Inhaled Nitric Oxide Market, value chain analysis
• FIG 9.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 10.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 11.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 12.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 13.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 14.Global Inhaled Nitric Oxide Market, regional snapshot 2022 & 2032
• FIG 15.North America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 16.Europe Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 17.Asia pacific Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 18.Latin America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 19.Middle East & Africa Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 20.Global Inhaled Nitric Oxide Market, company market share analysis (2023)

Global Inhaled Nitric Oxide Market is valued approximately at USD 1.12 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.70% over the forecast period 2024-2032. Inhaled nitric oxide (iNO) is a medical gas used as a therapeutic agent to improve oxygenation in individuals facing certain respiratory difficulties. It works by expanding blood vessels in the lungs, promoting better blood flow to areas essential for effective oxygen exchange. Nitric oxide is a naturally produced molecule in the body, playing a role in vasodilation and regulating blood pressure. . iNO targets blood vessels surrounding oxygen-rich areas in the lungs, promoting relaxation and heightened blood flow to facilitate optimal oxygen uptake by red blood cells. This targeted action is essential in treating conditions such as neonatal respiratory treatment, chronic obstructive pulmonary disease, acute respiratory distress syndrome, others. Accordingly, iNO plays a vital role in managing vascular and oxygenation issues, especially in neonatal and critical care scenarios. The robust clinical evidence supporting the efficacy and safety of iNO therapy in adults is a key trend supporting the growth of the Global Inhaled Nitric Oxide Market.

The growth of the inhaled nitric oxide market is anticipated to surge significantly due to increased adoption for managing pulmonary disorders in infants and newborns, coupled with a rise in respiratory disorders prevalence and advancements in healthcare infrastructure. Also, there is growing awareness regarding inhaled nitric oxide's effectiveness in treating various pulmonary conditions, especially in neonates, which is supporting the market expansion during the estimated period of 2024-2032. For instance, a 2022 article from the National Heart, Lung, and Blood Institute highlights the range of breathing problems affecting newborns, including transient tachypnea, neonatal respiratory distress syndrome (RDS), persistent pulmonary hypertension of the newborn (PPHN), meconium aspiration syndrome, and bronchopulmonary dysplasia (BPD). PPHN is a critical condition marked by heightened pulmonary vascular resistance is a primary indication for inhaled nitric oxide therapy. Its mechanism involves selective dilation of pulmonary blood vessels, enhancing oxygenation, and reducing reliance on invasive ventilation methods. Furthermore, the U.S. Food and Drug Administration's approval for inhaled nitric oxide in treating hypoxic respiratory failure further bolsters its adoption. Consequently, the surge in adoption of inhaled nitric oxide in order to manage respiratory complications in newborns is poised to drive the projected growth of the inhaled nitric oxide market. Furthermore, intensive research and development activities focused on inhaled nitric oxide are anticipated to present substantial growth opportunities within the market for this therapeutic gas. Inhaled nitric oxide has attracted considerable interest due to its promising therapeutic potential across a spectrum of pulmonary and cardiovascular conditions. The ongoing progress in medical science and technology has spurred investigations into innovative applications and formulations of inhaled nitric oxide, prompting heightened investments in research and development by pharmaceutical firms and research establishments. These initiatives aim to refine delivery mechanisms, dosage protocols, and broaden the scope of indications for inhaled nitric oxide therapy. However, stringent application norms across various regions, along with high costs incurred with the procedure is expected to hinder the market growth between 2022 and 2032.

The key regions considered for the global Inhaled Nitric Oxide Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is a dominating region in the inhaled nitric oxide market and is projected to sustain its leading position with the highest number of market shares throughout the forecast period. Key factors such as presence of advanced healthcare facilities and substantial healthcare expenditure levels that facilitate the adoption of innovative treatments like inhaled nitric oxide are primarily bolstering the regional market growth. Moreover, North America benefits from extensive research and development initiatives, coupled with a favorable regulatory landscape, which have fostered the advancement and commercial availability of inhaled nitric oxide products in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to the rising prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and neonatal hypoxic respiratory failure.

Major market player included in this report are:

• Air Liquide Healthcare (France)
• SOL Group (Italy)
• Matheson Tri-Gas Inc. (United States)
• Merck KGaA (Germany)
• Mallinckrodt Pharmaceuticals (United Kingdom)
• Nu-Med Plus Inc. (United States)
• Perma Pure LLC (United States)
• Praxair Distribution Inc. (United States)
• HALMA PLC (United Kingdom)
• LINDE PLC (Germany)

The detailed segments and sub-segment of the market are explained below:

By Application

• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease
• Acute Respiratory Distress Syndrome
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Inhaled Nitric Oxide Market Definition and Research Assumptions

• 1.1.Research Objective
• 1.2.Market Definition
• 1.3.Research Assumptions
  • 1.3.1.Inclusion & Exclusion
  • 1.3.2.Limitations
  • 1.3.3.Supply Side Analysis
    • 1.3.3.1.Availability
    • 1.3.3.2.Infrastructure
    • 1.3.3.3.Regulatory Environment
    • 1.3.3.4.Market Competition
    • 1.3.3.5.Economic Viability (Consumer's Perspective)
  • 1.3.4.Demand Side Analysis
    • 1.3.4.1.Regulatory frameworks
    • 1.3.4.2.Technological Advancements
    • 1.3.4.3.Environmental Considerations
    • 1.3.4.4.Consumer Awareness & Acceptance
• 1.4.Estimation Methodology
• 1.5.Years Considered for the Study
• 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

• 2.1.Global Inhaled Nitric Oxide Market Size & Forecast (2022- 2032)
• 2.2.Regional Summary
• 2.3.Segmental Summary
  • 2.3.1.By Application
• 2.4.Key Trends
• 2.5.Recession Impact
• 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Inhaled Nitric Oxide Market Dynamics

• 3.1.Market Drivers
• 3.2.Market Challenges
• 3.3.Market Opportunities

Chapter 4.Global Inhaled Nitric Oxide Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
  • 4.1.6.Futuristic Approach to Porter's 5 Force Model
  • 4.1.7.Porter's 5 Force Impact Analysis
• 4.2.PESTEL Analysis
  • 4.2.1.Political
  • 4.2.2.Economic
  • 4.2.3.Social
  • 4.2.4.Technological
  • 4.2.5.Environmental
  • 4.2.6.Legal
• 4.3.Top investment opportunity
• 4.4.Top winning strategies
• 4.5.Disruptive Trends
• 4.6.Industry Expert Perspective
• 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Inhaled Nitric Oxide Market Size & Forecasts by Application 2022-2032

• 5.1.Neonatal Respiratory Treatment
• 5.2.Chronic Obstructive Pulmonary Disease
• 5.3.Acute Respiratory Distress Syndrome
• 5.4.Others

Chapter 6.Global Inhaled Nitric Oxide Market Size & Forecasts by Region 2022-2032

• 6.1.North America Inhaled Nitric Oxide Market
  • 6.1.1.U.S. Inhaled Nitric Oxide Market
    • 6.1.1.1. Application breakdown size & forecasts, 2022-2032
  • 6.1.2.Canada Inhaled Nitric Oxide Market
• 6.2.Europe Inhaled Nitric Oxide Market
  • 6.2.1.U.K. Inhaled Nitric Oxide Market
  • 6.2.2.Germany Inhaled Nitric Oxide Market
  • 6.2.3.France Inhaled Nitric Oxide Market
  • 6.2.4.Spain Inhaled Nitric Oxide Market
  • 6.2.5.Italy Inhaled Nitric Oxide Market
  • 6.2.6.Rest of Europe Inhaled Nitric Oxide Market
• 6.3.Asia-Pacific Inhaled Nitric Oxide Market
  • 6.3.1.China Inhaled Nitric Oxide Market
  • 6.3.2.India Inhaled Nitric Oxide Market
  • 6.3.3.Japan Inhaled Nitric Oxide Market
  • 6.3.4.Australia Inhaled Nitric Oxide Market
  • 6.3.5.South Korea Inhaled Nitric Oxide Market
  • 6.3.6.Rest of Asia Pacific Inhaled Nitric Oxide Market
• 6.4.Latin America Inhaled Nitric Oxide Market
  • 6.4.1.Brazil Inhaled Nitric Oxide Market
  • 6.4.2.Mexico Inhaled Nitric Oxide Market
  • 6.4.3.Rest of Latin America Inhaled Nitric Oxide Market
• 6.5.Middle East & Africa Inhaled Nitric Oxide Market
  • 6.5.1. Saudi Arabia Inhaled Nitric Oxide Market
  • 6.5.2. South Africa Inhaled Nitric Oxide Market
  • 6.5.3.Rest of Middle East & Africa Inhaled Nitric Oxide Market

Chapter 7.Competitive Intelligence

• 7.1.Key Company SWOT Analysis
• 7.2.Top Market Strategies
• 7.3.Company Profiles
  • 7.3.1.Air Liquide Healthcare (France)
    • 7.3.1.1.Key Information
    • 7.3.1.2.Overview
    • 7.3.1.3.Financial (Subject to Data Availability)
    • 7.3.1.4.Product Summary
    • 7.3.1.5.Market Strategies
  • 7.3.2.SOL Group (Italy)
  • 7.3.3.Matheson Tri-Gas Inc. (United States)
  • 7.3.4.Merck KGaA (Germany)
  • 7.3.5.Mallinckrodt Pharmaceuticals (United Kingdom)
  • 7.3.6.Nu-Med Plus Inc. (United States)
  • 7.3.7.Perma Pure LLC (United States)
  • 7.3.8.Praxair Distribution Inc. (United States)
  • 7.3.9.HALMA PLC (United Kingdom)
  • 7.3.10.LINDE PLC (Germany)

Chapter 8.Research Process

• 8.1.Research Process
  • 8.1.1.Data Mining
  • 8.1.2.Analysis
  • 8.1.3.Market Estimation
  • 8.1.4.Validation
  • 8.1.5.Publishing
• 8.2.Research Attributes